Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in disease, today announced that multiple abstracts will ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced two poster ...

Wheeling University students took center stage on Thursday during the school’s 2026 Research Day and Scholarship ...

The e-posters will be available for browsing at the AACR virtual meeting platform beginning at 12:00 PM PT on April 17, as well as on the OBI Pharma website ( beginning on April 18. 1 AACR Annual ...

Image Courtesy of Anthony Curioso By Anthony Curioso In keeping with its “R1” status as one of the top research universities ...

Students at the U of A will have multiple opportunities to explore, present and engage with research during Undergraduate Research Week, set for April 20-23 across campus.

Adobe’s new AI workflow automates the jump from raw research to polished slides by syncing Acrobat’s data analysis with Adobe ...

Opus Genetics and Viatris (through its affiliate) are parties to a global licensing agreement which provides for the development of phentolamine ophthalmic solution 0.75% and grants exclusive rights ...

AI adoption, cybersecurity threats, and rising operational complexity are increasing and disrupting organizations at an unprecedented pace. Many lack a defined strategy to address these concerns in ...

Presentation in the New Drugs on the Horizon session to feature the development of NEO-811, a novel ARNT (HIF-1β)-targeted therapy in clear cell ...

In this edition of the biotech bi-weekly, get the latest biotech industry updates, with special focus on the upcoming AACR ...